ArticlePediatric radiology2026
Ultrafast shear-wave elastography for pediatric deep vein thrombosis: a prospective feasibility study.
Article in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the feasibility of ultrafast shear-wave elastography (SWE) for quantifying thrombus stiffness in pediatric deep vein thrombosis (DVT), and to explore changes over time. MATERIALS AND
methodsIn this single-center prospective study, pediatric patients (<18 years) with ultrasound-confirmed DVT were prospectively enrolled. Bedside SWE ultrasound was performed using a research platform (Vantage-256, Verasonics, Kirkland, Washington, USA) with a 6.9-MHz linear transducer. Mean shear-wave velocity was computed using MATLAB software. To assess shear-wave velocity (SWV) changes over time (exploratory analysis), SWE was planned at three timepoints (0-5 days, 6 days-6 weeks, and 6-16 weeks from DVT diagnosis). Feasibility was defined as the ability to obtain SWV measures. Changes in SWV over time in patients with ≥2 successful SWE were estimated using generalized estimating equations. The model was adjusted for patient age at DVT and sex.
resultsIn total, 35 patients (median age 1.4 years [range, 0.0-17.6], 63% male) were enrolled. SWE was successful in 19 patients, with a higher frequency of success in older patients and in occlusive DVTs. Fifteen of the 19 patients had ≥2 SWE. We documented an increase in SWV over time, with an increase in mean velocity of 0.012 m/s per day (P<0.001). Older age at DVT and female sex were associated with increased SWV, independent of time from index DVT.
conclusionsUltrafast SWE was feasible in pediatric DVT, particularly in older patients and in those with occlusive DVT. In exploratory longitudinal analyses, SWV increased over time, supporting further investigation of ultrafast SWE as a non-invasive quantitative biomarker of thrombus maturation in children.
Indexed as
Identifiers
42550209What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.